HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") announces the departure of Mr. Rick Brar as Vice-Chair of the board of directors of the Company ("Board") and as a director of the Company, effective immediately. The Company expresses its appreciation for Mr. Brar's services to the Company and wishes him well in his future endeavours.
On behalf of the Board, Mr. Vic Neufeld, Chairman of the Board, stated, "Mr. Brar has been instrumental in helping HAVN Life navigate the psychedelic sector as a start-up company in a nascent industry. We recognize the time commitments he has with his involvement in other businesses and truly appreciate his efforts and participation in our journey."
On Behalf of The Board of Directors
Tim Moore
CEO
About HAVN Life Sciences Inc.
HAVN Life Sciences Inc. is a Canadian biotechnology company pursuing standardized extraction of psychoactive compounds, the development of natural healthcare products, and innovative mental health treatment to support brain health and enhance the capabilities of the mind. Learn more at: havnlife.com and follow us on Facebook, Twitter and Instagram.
The CSE has not reviewed, approved or disapproved the content of this press release
| Last Trade: | US$0.01 |
| Daily Volume: | 0 |
| Market Cap: | US$147K |
October 27, 2022 July 21, 2022 June 07, 2022 | |
Else Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORE
Surf Air Mobility is a regional air mobility platform expanding the category of regional air travel to reinvent flying through the power of electrification. In an effort to substantially reduce the cost and environmental impact of...
CLICK TO LEARN MORE
